Vikram Deshpande
Anatomic Pathology & Clinical Pathology · Boston, MANPI 1083605513
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,650 of the $20,680 with a category attached, or 90.2%. 4 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 48.7% of the total. Reporting peaked in 2021 at $10,075 and has fallen 77.7% since, to $2,250 in 2023. Among anatomic pathology & clinical pathology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $861.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$10K
- Incyte Corporation$8K
- Leica Microsystems Inc.$2K
- Agios Pharmaceuticals, Inc.$19
Across 3 payments — averaging $107,302 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Agios Pharmaceuticals, Inc.$322K
What the payments were for
- Consulting fees$18,65090%
- Travel & lodging$1,8349%
- Food & beverage$1961%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $10,075 |
| Incyte Corporation | 21 | $8,336 |
| Leica Microsystems Inc. | 1 | $2,250 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
How this compares
$20,680 in reported general payments places this provider in the 90th percentile of 196 anatomic pathology & clinical pathology providers in Massachusetts.
See all anatomic pathology & clinical pathology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Boston
- Jason BaronBoston$336K
- Manlio LoconteBoston$112K
- Lida HaririBoston$47K
- Omer YilmazBoston$28K
- Lance TruongBoston$25K
- John BrandaBoston$23K
- Nancy MillerBoston$15K
- Lynne UhlBoston$14K
- Scott RodigBoston$14K
- Kyle DevinsBoston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.